GGrantIndex
Sort

51,593 grants matching hepatitis

Core--Clinical Facility

$427,324
Ian Frank · University Of Pennsylvania · P30 · FY2007 · AI

GENETIC ANALYSIS OF CORONAVIRUS ASSEMBLY INTERACTIONS

$427,273
Paul Scott Masters · Wadsworth Center · R01 · FY2006 · AI

Regulation of Hepatic Glucose Fluxes

$427,214
Roger Gutierrez-Juarez · Albert Einstein College Of Medicine · R01 · FY2009 · DK

Mechanistic enzymology of quinolinic acid biosynthesis

$427,156
Tadhg P. Begley · Cornell University · R01 · FY2008 · GM

ApoJ as a novel hepatokine targeting muscle glucose metabolism

$427,100
Young-Bum Kim · Beth Israel Deaconess Medical Center · R01 · FY2017 · DK

The National Drug Abuse Treatment Clinical Trials Network

$427,086
Walter Nmn Ling · University Of California Los Angeles · U10 · FY2012 · DA

Novel determinants of fibrinogen pro-repair activity in acetaminophen-induced liver toxicity

$427,081
James P Luyendyk · Michigan State University · R01 · FY2019 · DK

National HIV Behavioral Surveillance among MSM, IDUs and Heterosexuals in Houston

$427,055
Salma A Khuwaja · Houston Department/Health/Human Srvs · U1B · FY2015 · PS

Hepatic degradation of cytochrome P450 enzymes

$427,002
Maria Almira Correia · University Of California, San Francisco · R01 · FY2014 · GM

Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs

$426,986
Macrae F Linton · Vanderbilt University Medical Center · R01 · FY2016 · HL

NRF2 - SIRT1 SIGNALING AXIS IN LIVER TRANSPLANT REJUVENATION

$426,948
Jerzy W. Kupiec-Weglinski · University Of California Los Angeles · R01 · FY2018 · DK

NRF2 - SIRT1 SIGNALING AXIS IN LIVER TRANSPLANT REJUVENATION

$426,948
Jerzy W. Kupiec-Weglinski · University Of California Los Angeles · R01 · FY2019 · DK

NRF2 - SIRT1 SIGNALING AXIS IN LIVER TRANSPLANT REJUVENATION

$426,948
Jerzy W. Kupiec-Weglinski · University Of California Los Angeles · R01 · FY2017 · DK

NRF2 - SIRT1 SIGNALING AXIS IN LIVER TRANSPLANT REJUVENATION

$426,948
Jerzy W. Kupiec-Weglinski · University Of California Los Angeles · R01 · FY2020 · DK

NRF2 - SIRT1 SIGNALING AXIS IN LIVER TRANSPLANT REJUVENATION

$426,948
Jerzy W. Kupiec-Weglinski · University Of California Los Angeles · R01 · FY2016 · DK

Simianizing hepatitis C: Defining the species-tropism of a hepatotropic virus

$426,849
Charles M. Rice · Rockefeller University · R01 · FY2011 · AI

Characterizing the VZV-induced inflammatory response in temporal arteries from patients with giant cell arteritis

$426,845
Maria Acena Nagel · University Of Colorado Denver · P01 · FY2022 · AG

HEPATIC GENE TRANSFER FOR TREATMENT OF HEMOPHILIAS A &B

$426,844
Stanford University · R01 · FY2001 · HL

Testing Activated Charcoal as Adjunct Treatment for Severe Malaria

$426,790
Rick Fairhurst · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

T CELL RESPONSES IN LIVER GENE THERAPY

$426,749
James M Wilson · University Of Pennsylvania · P01 · FY2013 · HL

New Approaches To Passive Immunoprophylaxis

$426,742
Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Role of ATG14 in the regulation of hepatic function

$426,682
Xiaocheng Charlie Dong · Indiana University Indianapolis · R01 · FY2020 · DK

OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE

$426,654
Samuel Klein · Washington University · R01 · FY2006 · DK

Regulation of altered memory CD8 T cell differentiation by co-infection and prolo

$426,560
E. John Wherry · University Of Pennsylvania · U19 · FY2012 · AI

Aflatoxin Biosynthesis and Iterative Type I Polyketide Synthases

$426,546
Craig A Townsend · Johns Hopkins University · R01 · FY2010 · ES